Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Oct;56(10):629-632.
doi: 10.3928/23258160-20250718-02. Epub 2025 Aug 11.

Coats-like Retinopathy Associated With 18p Deletion Syndrome

Affiliations
Case Reports

Coats-like Retinopathy Associated With 18p Deletion Syndrome

Jeremia E Williams et al. Ophthalmic Surg Lasers Imaging Retina. 2025 Oct.

Abstract

This report examines a case of a novel association of Coats-like retinopathy and 18p deletion syndrome (18p-) and proposes a pathogenic mechanism for the association. A 4-year-old boy with 18p- presented with vision loss due to abnormal retinal vasculature associated with macular lipid exudate and exudative retinal detachment. Fluorescein angiography confirmed peripheral capillary nonperfusion, telangiectasias, and exudation. The left eye was normal. The patient was treated with indirect laser panretinal photocoagulation. Examination 6 years post-treatment revealed stable visual acuity at 20/70, with no recurrence of exudation or fluid. A plausible explanation for association of 18p- and Coats-like retinopathy involves overexpression of the homeobox gene DUX4, which can result from 18p deletion. Over-expression of DUX4 causes facioscapulohumeral muscular dystrophy (FSHD), a genetic muscle disorder also associated with Coats disease. This case suggests the possibility of a spectrum of findings caused by DUX4 overexpression, which may include exudative retinopathy in the absence of systemic FSHD.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors have disclosed no potential conflicts of interest, financial or otherwise.

Publication types

Substances